PD-1–targeted cis-delivery of an IL-2 variant induces a multifaceted antitumoral T cell response in human lung cancer | Science Translational Medicine
Human intratumoral T cells treated with PD1-IL2v up-regulate chemotactic and effector molecules, leading to a potent antitumor response.
